Nanobiomedicine Editor-in-Chief and Editorial Board Members to take the stage at Science Shaping Our World - SHOW
September 7, 2014
We are thrilled to announce that two of our Nanobiomedicine journal Editorial Board Members, Omar A. Ali and Qimin Quan, will be taking the stage at the "Science Shaping Our World - SHOW". The event will take place on October 16th at Merck Research Laboratories, 33 Avenue Louis Pasteur, Boston (MA). The registration fee for all wishing to attend is $15,00. To register, please click here.
This exceptional event is an ongoing seminar and networking series focused on the latest translational life science research and development. The main purpose of SHOW is to gather a multidisciplinary audience of both academia and industry individuals to learn about the most recent life science advancements and draw further research ideas from the latter.
Omar A. Ali is a Ph.D. student at the Harvard School of Engineering and Applied Sciences. In 2013, he helped translate the first material-based cancer vaccine into clinical testing in melanoma patients in collaboration with Wyss Institute and Dana Farber Cancer Institute. Qimin Quan is a junior fellow and principle investigator at Rowland Institute at Harvard University. His recent innovations include the development of CMOS compatible photonic crystal single molecule biosensor, as well as the label-free nano-bioprobe to detect intracellular proteins in single cells.
Furthermore, Nanobiomedicine Editor-in-Chief, Dr. Winston Patrick Kuo, will present the journal to all attendees at the event.